Back to today’s briefing

Story perspectives

Shocking Report: Cancer Drugs Fail Safety Tests Worldwide

6/30/2025

33 3

Summary

Story summary

A shocking report from the Bureau of Investigative Journalism uncovers that vital cancer drugs, such as cisplatin and doxorubicin, sent to over 100 countries, have failed crucial quality tests. These treatments, designed to combat cancer, may pose serious risks, igniting fears about their safety and effectiveness for patients worldwide.

1 of 1

Story summary

A shocking report from the Bureau of Investigative Journalism uncovers that vital cancer drugs, such as cisplatin and doxorubicin, sent to over 100 countries, have failed crucial quality tests. These treatments, designed to combat cancer, may pose serious risks, igniting fears about their safety and effectiveness for patients worldwide.